Hepatitis B marker seroprevalence and vaccination coverage in adolescents in the City of Itajaí, State of Santa Catarina, Southern Brazil, in 2008;Soroprevalência de marcadores da hepatite B e cobertura de vacinação em adolescentes no município de Itajaí, Estado de Santa Catarina Sul do Brasil, em 2008

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 44, Issue 4, 2011, Pages 416-419

  Tonial, Gabriela Chiochetta ^a   Passos, Ana Maria ^a   do Livramento, Andréa ^a   Scaraveli, Natália Gazzoni ^a   Batschauer, Anna Paula de Borba ^b   Bueno, Ednéia Casagrande ^b   Largura, Álvaro ^c   Spada, Celso ^a   Treitinger, Aricio ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

^c Instituto de Investigacao Cientifica do Parana   (Brazil)

Author keywords

Hepatitis B; Prevalence; Vaccination

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIGEN;

ADOLESCENT; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; BRAZIL; CHILD; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HIGH SCHOOL STUDENT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEROPREVALENCE; VACCINATION;

ADOLESCENT; BIOLOGICAL MARKERS; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

HEPATITIS B VIRUS;

EID: 81455138249     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822011000400003     Document Type: Article

References (42)

1. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002; 40:4068-4071.
2. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2004;79:255-263.
3. Ministério da Saúde. Doenças Infecciosas e Parasitárias: Guia de Bolso. Brasília: Departamento de Vigilância Epidemiológica; 2004.
4. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28:112-125.
5. Ministério da Saúde. Manual de aconselhamento em hepatites virais. Brasília: Departamento de Vigilância Epidemiológica; 2005.
6. Ministério da Saúde. Programa Nacional de Imunizações: PNI 25 anos. Brasília: Fundação Nacional de Saúde; 1998.
7. Ministério da Saúde [Internet]. Ministério da Saúde amplia grupo da vacina da hepatite B [cited Oct 2010]. Available from: http://portal.saude.gov.br/portal/ arquivos/.
8. Gish RG, Gadano AC. Chronic hepatitis B: Current epidemiology in the Americas and implications for management. J Viral Hepat 2006; 13:787-798.
9. Andrade AFB, Silva MO, Silva SGC, Motta IJF, Bonvicino CR. Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005. Mem Inst Oswaldo Cruz 2006; 101:673-676.
10. Nascimento MC, Mayaud P, Sabino EC, Torres KL, Franceschi S. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. J Med Virol 2008; 80:53-57.
11. Treitinger A, Spada C, Ferreira LA, Strazzer Neto M, Reis M, Verdi JC, et al. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis-Brazil. Braz J Infect Dis 2000; 4:192-196.
12. Rosini N, Mousse D, Spada C, Treitinger A. Seroprevalence of HBsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001. Braz J Infect Dis 2003; 7:262-267.
13. Treitinger A, Spada C, Silva EL, Miranda AF, Oliveira OV, Silveira MV, et al. Prevalence of serologic markers of HBV and HCV infection in HIV-1 seropositive patients in Florianópolis-Brazil. Braz J Infect Dis 1999; 3:1-5.
14. Pereira RARA, Mussi ADH, Silva VCA, Souto FJD. Hepatitis B virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil. BMC Infect Dis 2006; 6:34.
15. Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, et al. Changing Epidemiology of HCV and HBV Infections in Northern Italy: A Survey in the General Population. J Clin Gastroenterol 2008; 42:527-532.
16. Motta VT, Wagner MB. Bioestatística. Caxias do Sul: Educs; 2003.
17. Ministério da Saúde. Secretaria de Vigilância em Saúde. Material instrucional para capacitação em vigilância epidemiológica das hepatites virais. Brasília: Ministério da Saúde; 2008.
18. Ministério da Saúde. Hepatites Virais: O Brasil Está Atento. 3a ed. Brasília: Ministério da Saúde; 2008.
19. Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C, et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine 2003; 21:685-691.
20. Salleras L, Dominguez A, Bruguera M, Cardeñosa N, Batalla J, Carmona G, et al. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain). Vaccine 2005; 23:2181-2184.
21. McQuillan GM, Townsend TR, Fields HA, Carroll M, Leahy M, Polk BF. Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. Am J Med 1989; 87:5-10.
22. Pereira LM, Martelli CM, Merchán-Hamann E, Montarroyos UR, Braga MC, de Lima ML, et al. Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg 2009; 81:240-247.
23. Voigt AR, Strazzer Neto M, Spada C, Treitinger A. Seroprevalence of hepatitis B and hepatitis C markers among children and adolescents in teh south brazilian region - metropolitan area of Florianópolis, Santa Catarina. Braz J Infect Dis 2010; 14:60-65.
24. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol 2003; 18:551-557.
25. Cisneros-Castolo M, Hernandez-Ruiz L, Ibarra-Robles IE, Fernández-Gárate RH, Escobedo-De La Peña J. Prevalence of hepatitis B virus infection and related risk factors in a rural community of Mexico. Am J Trop Med Hyg 2001; 65:759-763.
26. Gandolfo GM, Ferri GM, Conti L, Antenucci A, Marrone R, Frasca AM, et al. Prevalence of infections by A, B, C and E viruses in two different socioeconomic groups of children from Santa Cruz, Bolívia. Med Clin 2003; 120:725-727.
27. Oliveira MDS, Martins RMB, Matos MA, Ferreira RC, Dias MA, Carneiro MA, et al. Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang® vaccine in adolescents from low income families in Central Brazil. Mem Inst Oswaldo Cruz 2006; 101:251-256.
28. Ministério da Saúde. Secretaria de Vigilância em Saúde. Sistema nacional de vigilância em saúde: relatório de situação - Santa Catarina. Brasília: Ministério da Saúde; 2007.
29. International Group. Immunization against hepatitis B. Lancet 1988; 1:875-876.
30. Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379-1384.
31. Ferreira CT, Silveira TR. Viral hepatitis prevention by immunization. J. Pediatr 2006; 82 (supl): 55-66.
32. Giambi C, Bella A, Barale A, Montù D, Marchisio M, Oddone M, et al. A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines. BMC Infect Dis 2008; 8:100.
33. Bialek SR, Bower WA, Novak R. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis b vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J 2008; 27:881-885.
34. Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007; 25:6958-6964.
35. But DY, Lai CL, Lim WL, Fung J, Wong DK, Yuen MF. Twenty-two years followup of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine 2008; 26:6587-6591.
36. McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009; 200:1390-1396.
37. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis. Vaccine 2010; 28:623-631.
38. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010; 28:730-736.
39. Arslanoglu I, Cetin B, Isguven P, Karavus M. Anti-HBs response to Standard Hepatitis B vaccination in children and adolescents with diabetesmellitus. J Pediatr Endocrinol Metab 2002; 15:389-395.
40. Cook IF, Murtagh J. Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants. J Paediatr Child Health 2002; 38:393-396.
41. Abraham B, Baine Y, De-Clercq N, Tordeur E, Gerard PP, Manouvriez PL, et al. Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine. Antiviral Res 2002; 53:63-73.
42. Cassidy WM. Adolescent hepatitis B vaccination. A review. Minerva Pediatr 2001; 53:559-566.